Peer Review reports
From: CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer
| Original Submission | ||
|---|---|---|
| 4 Apr 2022 | Submitted | Original manuscript |
| 5 Jun 2022 | Reviewed | Reviewer Report |
| 29 Jul 2022 | Reviewed | Reviewer Report |
| 11 Aug 2022 | Author responded | Author comments - Hairu Ji |
| Resubmission - Version 2 | ||
| 11 Aug 2022 | Submitted | Manuscript version 2 |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| 7 Sep 2022 | Reviewed | Reviewer Report |
| 17 Sep 2022 | Reviewed | Reviewer Report |
| 3 Oct 2022 | Author responded | Author comments - Hairu Ji |
| Resubmission - Version 4 | ||
| 3 Oct 2022 | Submitted | Manuscript version 4 |
| 12 Oct 2022 | Author responded | Author comments - Hairu Ji |
| Resubmission - Version 5 | ||
| 12 Oct 2022 | Submitted | Manuscript version 5 |
| 15 Oct 2022 | Author responded | Author comments - Hairu Ji |
| Resubmission - Version 6 | ||
| 15 Oct 2022 | Submitted | Manuscript version 6 |
| 21 Oct 2022 | Reviewed | Reviewer Report |
| Resubmission - Version 7 | ||
| Submitted | Manuscript version 7 | |
| Publishing | ||
| 25 Oct 2022 | Editorially accepted | |
| 31 Oct 2022 | Article published | 10.1186/s12920-022-01383-w |
You can find further information about peer review here.